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ABSTRACT 
Cluster of Differentiation (CD) proteins are proteins found in the cell membranes 
of leukocytes. These proteins are important because they are cell surface markers for 
many immune cells and can be used as therapeutic and diagnostic targets. Biophysical 
methods like X-ray crystallography and nuclear magnetic resonance (NMR) are 
commonly used to determine the function of proteins through the generation of their 
three-dimensional structures. However, applications of these experimental methods do 
not work very well in order to determine the function of membrane proteins because of 
their high flexibility and instability, their partial hydrophobic surface, and the 
requirement of highly specific detergents for their extraction from phospholipids 
membranes. In order to address this problem, we devised a theoretical approach where 
type I CD proteins can be classified into two different functional groups (enzyme and 
non-enzyme) by using physicochemical parameters related to the primary sequence of the 
individual CD proteins. Principal component analysis (PCA) was used to analyze 126 
parameters of 244 type I CD proteins. Two different clusters of type I CD proteins with 
enzymatic activity and non-enzymatic activity were found on the score plot, and the 
separation of those clusters was found to be statistically significant. Cytoplasmic amino 
acid count was found to be the most important variable for separating enzymes and non-
enzymes. The continuous probability densities of CD proteins with enzymatic activity 
and non-enzymatic activity were then approximated by kernel density estimation (KDE) 
of cytoplasmic amino acid count. This is the first time this method of determining type I 
CD proteins functional classes has been employed and appears quite promising. In the 
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future, this statistical approach could be very useful in determining the functional class of 
newly discovered or poorly characterized type I CD proteins. 
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Chapter I  
INTRODUCTION 
Proteins are important macromolecules found in living organisms. According to 
Alberts et al. (2002), proteins exhibit a wide variety of functions, such as: catalysts, 
signal receptors, switches and motors. This huge diversity in protein function is attributed 
to their ability to bind with specific molecules. There are two broad classifications of 
proteins: water-soluble proteins and membrane proteins. Water-soluble proteins are found 
in the aqueous medium, and they fold into globular structure, because the amino acids 
found in their interior are mostly hydrophobic while the amino acids found on the surface 
are hydrophilic (Berg, Tymoczko, and Stryer, 2002). Membrane proteins consist of 
integral membrane proteins and peripheral membrane proteins. While peripheral 
membrane proteins are found on the surface of the phospholipid bilayer, integral 
membrane proteins have one or more transmembrane domains embedded in the 
hydrophobic phospholipid bilayer core and have mostly hydrophobic amino acids. 
Cytosolic and exoplasmic domains are found in aqueous mediums, and have mostly 
hydrophilic amino acids (Lodish et al., 2000). The study of membrane proteins presents 
major challenges, because they can only be studied in vitro, outside of their native 
membranes where they are often flexible and unstable, and specific detergents are 
required to keep them functionally stable (Carpenter, Beis, Cameron, and Iwata, 2008). 
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Seddon, Curnow, and Booth (2004) state three major challenges while studying 
the three-dimensional structures of membrane proteins. The first challenge is acquiring 
the desired protein types. A wide variety of membrane protein types are present in the 
membranes of most cells and are usually present in low quantity. To enhance the yield of 
desired protein, heterologous expression is used. This works well for water-soluble 
proteins. However, for membrane proteins, the expressed proteins aggregate in the 
cytoplasm of the heterologous host. Similarly, for mammalian proteins, post- 
transcriptional modifications are required to generate functional proteins, but 
heterologous hosts are devoid of those mechanisms. The second major challenge arises 
from the fact that the phospholipid membrane provides a complex, heterogeneous, and 
dynamic environment to membrane proteins. Thus, to study the structure of membrane 
proteins using standard biophysical methods (NMR and X-ray crystallography) samples 
need to be prepared in vitro using a detergent/lipid medium. Unless a highly appropriate 
detergent/lipid is selected, there is a high probability that erroneous results might be 
obtained due to the spectral contributions from the lipid/detergents. The third major 
challenge to studying membrane proteins is the preparation of a synthetic system that 
emulates the behavior of the protein of interest in its native environment. Creating the 
lipid/detergent environment where the isolated membrane proteins retain their native 
structure and function is very challenging. 
One of the most important steps in the reconstruction of membrane proteins 
during in vitro studies of three-dimensional structure is solubilization. Solubilization is 
necessary because if the transmembrane proteins are separated from the membrane, their 
hydrophobic portions will interact with one other, causing them to precipitate out of the 
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solution (Lodish et al., 2000). Moreover, difficulty exists in other areas including: 
expression, purification, crystallization, data collection and structure solution for 
membrane proteins. According to Carpenter et al. (2008), the selection of an appropriate 
detergent is critical for biochemical methods used to determine three-dimensional 
structure of proteins (i.e., isolation, purification, solubilization and recrystallization). This 
problem is so prevalent that among all the membrane proteins currently available in the 
PDB database, less than 1% of them have been successfully crystallized (Parker & 
Newstead, 2016). Hence, there is a great need for alternative theoretical methods that can 
accurately predict the functions of membrane proteins.  
To address this problem, an alternative theoretical approach was developed, 
where bioinformatics and multivariate statistics tools were used to categorize type I CD 
proteins into two distinct groups, based on their functional relevance, simply by 
analyzing their physicochemical characteristics derived from their amino acid sequence. 
According to Zola, Swart, Nicholson, and Elena (2007), the amino acid sequence of a 
protein determines its three-dimensional structure, which then dictates the function of the 
protein. Based on this fact, we formed a scientific hypothesis: by analyzing 126 different 
physicochemical properties (directly related to their primary sequence) of 244 type I CD 
proteins, they can be classified into two broad categories based on function: Enzymes and 
Non-enzymes.  
 The purposes of this thesis were: 1) to classify the type I CD proteins into distinct 
groups based on function (enzymes or non-enzymes); 2) to use principal components 
analysis to identify the variable (out of 126 different variables) that contributed the most 
in separating enzyme and non-enzyme; 3) to predict the likelihood of a novel type I CD 
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protein being an enzyme or non-enzyme based on the probability distribution of currently 
available type I CD proteins using the highest contributing variable. We found out that, 
just by using bioinformatics datasets and multivariate statistics tools (and few others 
statistical tools), type I CD proteins can be classified into two groups: enzymes and non-
enzymes. Using the kernel density estimation of the most important variables, the 
likelihood of a newly discovered type I CD protein being enzyme or non-enzyme can be 
predicted. 
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Chapter II 
LITERATURE REVIEW 
Membrane Proteins 
There are two broad categories of membrane proteins: integral membrane proteins 
and peripheral membrane proteins. Integral membrane proteins span through the plasma 
membrane, while peripheral membrane proteins are found on the surface of the 
membrane (Lodish et al., 2000). Furthermore, integral membrane proteins can be grouped 
into different classes based on the orientation of N-terminus and C-terminus of the 
polypeptide chain. For type I integral membrane proteins, the N-terminus lies outside of 
the cell, while the C-terminus lies in the cytoplasm. The signal sequence from the protein 
is cleaved before it is transported to the cell membrane. For type II integral membrane 
proteins, the C-terminus lies outside of the cell membrane, while the N-terminus of the 
polypeptide lies in the cytoplasm. In type II integral membrane proteins, the N-terminus 
cytoplasmic sequence is short and no cleavage of the protein occurs. Type III and type IV 
proteins are both multipass proteins. Type V protein is attached to the membrane by its 
C-terminus through glycosyl-phosphatidylinositol (GPI linked) (Zola et al., 2007). Our 
research focuses on the type I class of integral membrane proteins.  
Principal Component Analysis (PCA) 
Principal component analysis (PCA) is a multivariate statistics tool which 
analyzes the observations from multiple correlated variables such that important 
information can be obtained. The purpose of applying PCA is to reduce the 
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dimensionality of potential predictor variables by identifying which variables best explain 
the variance in the data set. PCA computes the new set of orthogonal variables called 
principle components (PCs). The number of PCs obtained after principal components 
analysis is the same as the number of variables for the original dataset. The first PC 
(PC1) explains the highest amount of the variance from the original dataset. The second 
PC (PC2) is orthogonal to PC1 and is responsible for the second highest amount of 
variance. The remaining PCs are computed in a similar way. Each observation has score 
values for each principal component, which can be plotted to observe the distribution of 
the whole dataset based on the new dataset. When the most important PCs are retained 
(and the PCs carrying noise are excluded) and their score values are plotted, a clear and 
concise picture of the distribution of the data can be observed (Abdi & Williams, 2010). 
Parallel Analysis 
Parallel analysis is the most effective statistical method to determine the optimal 
number of principal components to be retained (Dinno, 2009). Most of the methods used 
to determine the optimal number of principal components are subjective. This results in 
either the loss of information in the case of under-extraction or inclusion of noise, which 
affects subsequent analysis in the case of over-extraction (Franklin et al., 1995). Parallel 
analysis uses Monte Carlo simulation to generate a random dataset equal to the original 
data set in terms of number of observations and variables. Horn’s parallel analysis 
performs PCA on random datasets (uncorrelated variables) and the original dataset in 
order to compare the eigenvalues between them and produce the principal components 
that are adjusted for sampling error-induced inflation. Only those principal components 
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whose estimated bias (difference of unadjusted eigenvalues and adjusted eigenvalues) are 
greater than one are retained (Dinno, 2009).  
Kernel Density Estimation (KDE) 
Kernel Density Estimation (KDE) is a non-parametric method, which is used to 
predict the probability density function from a set of discontinuous measurements of a 
random variable. When plotting a histogram, data are binned into discrete classes and the 
bar represents the relative frequency of occurrence in that bin, whereas during KDE, a 
continuous distribution (of a specified shape and bandwidth) is centered on each data 
point and then all of the kernels are added to obtain the KDE (Deng & Wickham, 2011; 
Zambon & Dias, 2012). The most commonly used kernel weighting function is the 
Gaussian distribution, but other commonly used kernel weighting functions are 
Epanechnikov, Uniform, and Triweight. Once a kernel function is chosen, one must also 
select a bandwidth. When the bandwidth is too large, an overly smooth probability 
density estimate is generated, which will obscure important characteristics of the 
distribution. On the other hand, when the bandwidth is small, the distribution becomes 
noisy (Zambon & Dias, 2012). 
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Chapter III 
 MATERIALS AND METHODS 
Data Retrieval 
Retrieval of Type I Protein List 
A CD protein list was obtained from www.hcdm.org (Engel et al., 2015). Out of 
371 CD protein molecules found on hcdm.org, 244 of them were identified as type I CD 
proteins using a bioinformatics protein database called UniProt Knowledgebase 
(UniProtKB) (Breuza et al., 2016). The type of CD protein was accessed from the 
“Subcellular Location” panel of UniProtKB for each type I CD protein from the list. The 
correct UniProtKB accession number was obtained for each type I CD protein. In order to 
verify if the CD proteins obtained from hcdm.org were the same as the proteins that were 
used in UniProtKB, alternative names were matched from both websites.  
For each type I CD protein, 126 different sequence parameters were selected. 
These parameters were primary and secondary physicochemical characteristics, which 
were obtained from the primary amino acid sequence of each type I CD proteins using 
various bioinformatics tools. 
Retrieval of Protein Sequence 
In order to obtain the sequence for each type I CD protein, the UniProtKB 
accession number was entered in the UniProtKB search toolbar. The “Feature Table”
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displayed protein features such as: topology, molecular processing, secondary structure 
etc. The sequence for each topological domain: extracellular, transmembrane, and 
cytoplasmic were retrieved from the topology tab under “Feature Table.” 
Retrieval of Regional Amino Acid Count  
The regional amino acid count (extracellular amino acid count, transmembrane 
amino acid count, and cytoplasmic amino acid count) were extracted from the subcellular 
location panel of UniProtKB. The number of amino acids in each topological domain 
were recorded in Excel for each type I CD protein. 
Total Amino Acid Count Calculation 
The total amino acid count for each type I CD protein was obtained by summing 
up each regional amino acid count. The signal peptide sequence was excluded from the 
total amino acid count calculation. 
Retrieval of Charges  
The positive and negative charges for each topological domain: extracellular, 
transmembrane, and cytoplasmic were extracted by using ExPASy ProtParam tool under 
the “Sequence” feature of UniProtKB (Gasteiger et al., 2005). The total positive charge 
was calculated by summing the positive charges from each topological region. Similarly, 
the total negative charge was calculated by summing the negative charges for each 
topological region. The total charge was calculated by subtracting total negative charge 
from total positive charge. Similarly, the absolute charges were calculated by taking the 
absolute value of total extracellular charges, total transmembrane charges and total 
cytoplasmic charges, respectively in Excel. Similarly, total absolute charges were 
calculated by taking absolute values of total charges. 
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Retrieval of Number of Amino Acids 
Retrieval of Number of Individual Amino Acid Type  
For each type I CD protein, the number of amino acids from each of the 20 
individual amino acids types were recorded separately using the ExPASy ProtParam tool. 
The numbers were recorded for each topological domain.  
Retrieval of Total Number of Each Individual Amino Acid Type 
The total number of each individual amino acid was recorded from the chain 
sequence tab of ExPASy ProtParam tool. The chain sequence tab excluded the signal 
peptide and included only the total amino acid sequence. To avoid mistakes, while 
recording the data, the entire set of amino acid numbers was copied directly into 
Microsoft Excel file from the ExPASy ProtParam tool’s screen. 
Retrieval of Theoretical Isoelectric Point (pI) 
The theoretical isoelectric point (pI) was retrieved from the amino acid sequence 
for each topological domain (extracellular, transmembrane and cytoplasmic) using the 
ExPASy ProtParam tool.  
Retrieval of Instability Index 
The instability index was retrieved from sequence fragments for each topological 
domain (extracellular, transmembrane and cytoplasmic) using the ExPASy ProtParam 
tool.  
Retrieval of Aliphatic Index 
The aliphatic index was retrieved from sequence fragments for each topological 
domain (extracellular, transmembrane and cytoplasmic) using the ExPASy ProtParam 
tool.  
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Retrieval of Grand Average of Hydropathicity  
The grand average of hydropathicity was retrieved from sequence fragments for 
each topological domain (extracellular, transmembrane and cytoplasmic) using the 
ExPASy ProtParam tool.  
Retrieval of Glycosylation Site for Extracellular Region 
The glycosylation site for extracellular region were retrieved using the 
PTM/Processing tab of UniProtKB. The total number of glycosylation position(s) located 
only in the extracellular domain was counted and recorded.  
Retrieval of Phosphorylation Site for Cytoplasmic Domain 
The amino acid sequences from the cytoplasmic domain for each type I CD 
protein were extracted from UniProtKB. The phosphorylation sites were computed by 
running the sequence in ExPASy: SIB Bioinformatics Resource Portal tool Netphos 2.0 
Server (Artimo et al. 2012; Blom, Gammeltoft, & Brunak, 1999). The total number of 
Serene, Threonine and Tyrosine residues predicted by the Netphos 2.0 neural network 
was recorded. The number of phosphorylation sites with less than 15 and more than 4000 
amino acid residues could not be computed by Netphos 2.0 server. For the cytoplasmic 
sequence with less than 15 amino acid residues, the number of phosphorylation sites was 
recorded as zero.  
Retrieval of Secondary Structure Content 
The amino acid sequences for the extracellular and cytoplasmic domain were 
extracted from UniProtKB. The secondary structure content was obtained by using the 
GOR IV tool of the ExPASy: SIB Bioinformatics Resource Portal (Sen, Jernigan, 
Garnier, & Kloczkowski, 2005). 
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Alpha Helix Content 
For each type I CD protein, alpha helix content (%) for extracellular and 
cytoplasmic domains were retrieved. 
Beta Sheet Content   
For each type I CD protein, beta sheet content (%) for extracellular and 
cytoplasmic domains were retrieved. 
Random Coil Content  
For each type I CD proteins, random coil content (%) for extracellular and 
cytoplasmic domain were retrieved.  
Retrieval of Disorder Average and Standard Deviation  
Disorder average and disorder standard deviation was calculated for each 
topological domain of type I CD proteins. The bioinformatics tool IUPred: Prediction of 
Intrinsically Unstructured Proteins (Dosztányi, Csizmok, Tompa, and Simon, 2005) was 
used to predict the disorder tendency for each amino acid residue. The average and 
standard deviation of disorder tendency was computed in MS Excel using the disorder 
tendency of individual residue, for each topological domain. While selecting the 
prediction criteria for IUPred, long disorder and raw data were used as prediction type 
and output type, respectively. 
Determination of Function (Enzyme or Non-Enzyme) 
To assess the functional category of each type I CD protein (enzyme or non-
enzyme), the information under the “Function” tab of UniProtKB was examined. Based 
on the information found under the “Function” tab, type I CD proteins with enzymatic 
activity were assigned as enzymes, and those with non-enzymatic activity (i.e., binding, 
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signal anchor) were assigned as non-enzymes. For those CD proteins that could not be 
clearly identified as having enzymatic activity or non-enzymatic activity, further 
investigation into scientific publications was made to clarify their functional class. 
Statistical Analysis 
Principal Component Analysis (PCA) 
 MiniTab 17 statistical software (2010) was used to perform principal component 
analysis (PCA) on the Type I CD protein dataset, with 244 observations and 126 different 
variables. While performing the PCA, the correlation matrix option was selected because 
the units and range of the values of the variables differed.  
Parallel Analysis to Determine the Number of Principal Components to be 
Retained 
Horn’s parallel analysis was performed to determine the number of principal 
components to be retained for the analysis. R’s ‘paran’ package was used to perform 
Horn’s parallel analysis (Dinno, 2012). 
Assessment of Statistical Significance of Separation of Enzymes and Non-
Enzymes from PCA Data 
Applying the methods used by Goodpaster and Kennedy (2011), the statistical 
significance of separation of enzymes and non-enzymes from the principal component 
analysis data was tested. The centroids for Enzymes and Non-Enzymes clusters were 
calculated from the PCA score value. The centroid values are the average score values for 
each principal component, from PC1 to PC10 for Enzymes and Non-Enzymes, 
respectively. The Mahalanobis distance (DM) was calculated as: 
 14 
  
 𝐷𝐷𝑀𝑀 = √𝑑𝑑′𝐶𝐶𝑤𝑤−1𝑑𝑑                                                   
where 𝑑𝑑 = 1×2 Euclidian difference vector between the centroids of enzymes and non-
enzymes, calculated as  
 𝑑𝑑 = �PC1(NE) −   PC1(E), PC2(NE) −   PC2(E), … … … … . . , PC10(NE) −   PC10(E)� 
and Cw-1 = Inverse of the pooled variance-covariance matrix between enzymes (E) and 
non-enzymes (NE). 
Here, V is the pooled variance-covariance matrix between enzyme (E) and non-
enzyme (NE). 
Hoteling’s T2 was calculated using the formula: 
𝑇𝑇2 = n1 .  n2
n1+n2
 𝑑𝑑′𝐶𝐶𝑤𝑤−1𝑑𝑑   
where n1 = 26 (number of Enzymes) and n2= 218 (number of Non-Enzymes). 
The Hoteling’s T2 can be converted into 𝐹𝐹-statistics by using the following formula: 
𝐹𝐹 = n1+ n2−p−1
p(n1+n2−2) 𝑇𝑇2  
In this case, p is the number of discriminator variables. Since, 10 principal components 
(PC1 to PC10) are being evaluated in this case, p = 10. 
The 𝐹𝐹-value is the ratio of between group variance to that of within group variance 
between enzyme and non-enzyme. 
Critical 𝐹𝐹-value =  F(p, n1 + n2 − p − 1) 
The critical 𝐹𝐹-value was calculated using 
http://www.danielsoper.com/statcalc/calculator.aspx?id=4 (Soper, 2017). The server 
required the number of degrees of freedom in the numerator, which is equal to two. The 
number of degrees of freedom in the denominator is given by the formula (n1 + n2 −
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p − 1 ), which equaled 241. The 𝐹𝐹-critical value was calculated at a significance level (α) 
of 0.05.  
To determine if the separation of type I CD proteins with enzymatic activity (as 
represented by blue dots in Figure 2) and with non-enzymatic activity (as represented by 
red dots in Figure 2) was statistically significant, the 𝐹𝐹-value computed using Hoteling’s 
T2 value and 𝐹𝐹-critical value was compared.  
Matrix Plot of Scores Values  
To observe the pattern of distribution of enzymes and non-enzymes in a two- 
dimensional scatter plot, a matrix plot was created where PCs (PC1 to PC10) were paired 
with one another. Forty-five different two-dimensional scatter plots were obtained in the 
matrix plot. Mahalanobis distance was computed between the centroid of enzymes and 
non-enzyme clusters for each individual scatter plot. By using the Mahalanobis distances, 
Hoteling’s T2 test and 𝐹𝐹-statistics were assessed. Out of 45 scatter plots, the PC that had 
the highest Mahalanobis distances and their corresponding T2 values and 𝐹𝐹-statistics 
values was be the best PC for separating enzymes and non-enzymes. 
Wilcoxon Ranked-Sum Test and Kernel Density Estimation (KDE) Plot 
  The Wilcoxon ranked-sum test was performed to if the variable that had highest 
loading value for the most important PC had the same distribution for enzyme and non-
enzyme data. R 3.4.2 was used to perform the analysis. Kernel Density Estimation (KDE) 
was used to plot the probability density estimation function for the non-parametric data of 
cytoplasmic amino acid count for enzymes and non-enzymes. The density function from 
the ‘stats’ package was used to perform KDE analysis (Bowman & Azzalini, 2014). 
Gaussian kernel and direct plug-in (dpi) from bw.SJ functions were used to calculate the 
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kernel type and bandwidth used. In order to integrate the kernel density function over 
different cytoplasmic AA count, R package sfsmisc was used (Maechler et al., 2017). 
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Chapter IV 
RESULTS 
Principal Component Analysis 
Scree Plot 
Based on the scree plot (Figure 1), 126 total principal components (PCs) were 
obtained. Among those 126 PCs, principal component 1 (PC1) and principal component 2 
(PC2) had eigenvalues of 42.504 and 20.967 respectively. The first ten PCs accounted for 
71.8 % of the total variance of the data.
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Figure 1. Scree plot of physicochemical characteristics of Type I CD proteins. 
Horn’s Parallel Analysis 
Horn’s parallel analysis was performed to determine the number of principal 
components to be retained. Based on Horn’s parallel analysis (Figure 2, Table 1), the first 
10 PCs were retained.  
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Figure 2. Horn’s Parallel Analysis plot to determine the optimal number of PCs retained. 
PCs with adjusted EV greater than 1 were retained. 
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Table 1. Components Retention of First 10 PCs (3780 Iterations). 
Component Adjusted Eigenvalue Unadjusted Eigenvalue Estimated Bias 
1 40.5995 42.45059 1.851084 
2 19.25349 20.98743 1.733934 
3 3.331805 4.979356 1.647551 
4 2.852459 4.42674 1.574281 
5 2.255807 3.76413 1.508323 
6 1.881135 3.329175 1.44804 
7 1.626716 3.018798 1.392082 
8 1.445181 2.785131 1.339949 
9 1.087669 2.377974 1.290304 
10 1.118029 2.36047 1.242441 
 
Matrix Plot for First 10 PCs Score Values 
After plotting the matrix plot of the first 10 PCs score values with each other, 45 
different combinations of unique two-dimensional scatter plots were obtained (Figure 3). 
It is clearly visible that all the scatter plots including PC2 had a higher separation of 
enzymes and non-enzymes cluster compared to the other 36 scatter plots where PC2 
score values were not used. This clearly indicates that among the first 10 PCs retained 
from Horn’s parallel analysis, PC2 was the most effective in separating enzymes and 
non-enzymes into two different clusters.  
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Figure 3. Matrix plot of score values for PC1 to PC10. All the score plots that involved 
PC2 yielded the greatest amount of separation between enzymes and non-enzymes. 
Separation of Enzyme (E) and Non-enzyme (NE) clusters. 
 Hoteling’s T2 and 𝐹𝐹-statistics for the enzyme group and the non-enzyme group 
were calculated using the score values for the first 10 PCs to find out if the separation of 
enzymes and non-enzymes clusters obtained after performing PCA was statistically 
significant (Table 2). Mahalanobis distance between the enzyme and non-enzyme groups 
was 7.014. The Hoteling’s T2 value obtained for enzyme and non-enzyme clusters was 
1142.824. The 𝐹𝐹-statistic calculated using Hoteling’s T2 value was 110.0322 and the 
critical value of 𝐹𝐹0.05,10,233 was 1.87. This signifies that when PCA was used for the type 
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I CD protein data, there was a statistically significant separation of enzyme and non-
enzyme clusters. 
Table 2. Mahalanobis Distance (Dm), Hoteling’s T2 and 𝐹𝐹-statistics between Enzyme and 
Non-enzyme Based on the First 10 PCs. 
 
For Enzymes and Non-enzymes (10 PCs) 
Mahalanobis Distance 
(Dm) 
7.014 
Dm2 49.197 
Hotelling’s T2 1142.82 
𝐹𝐹-statistics 110.032 
𝐹𝐹-critical 1.87 
 
 From the matrix plot, it was apparent that the two-dimensional score plots 
containing PC2 had the highest separation of enzyme and non-enzyme clusters. To test 
this observation objectively, the Mahalanobis distance and the corresponding T2 and 𝐹𝐹-
statistics for each individual score plot involving the first ten PCs were calculated 
(Appendix A).  
Loadings Plot for PC1 
Based on the loading values for PC1 (Appendix B, Figure 4), total amino acid 
count displayed the highest contribution to PC1, with a loadings value of 0.153. 
Similarly, other variables that have relatively high loadings values (in descending order) 
are total negative charges, total positive charges, total number of Glutamic acid (E), total 
number of Aspartic Acid(D), total number of Serine (S), total number of Arginine (R), 
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total number of Glycine(G), total number of Tyrosine (Y), and total number of Valine 
(V), respectively. The variables that are related to the entire type I protein (not just 
variables for particular topological domains) contribute the most to PC1 (Figure 4, 
Appendix B).  
 
Figure 4. Loadings plot for 126 protein characteristics using PC1.  
Loadings Plot for PC2 
Since PC2 was established as the most important PC to separate enzyme and non-
enzyme clusters, PC2 loading values were analyzed to identify the variable that showed 
the highest contribution to PC2. The loading values were plotted in MS Excel to obtain 
the loadings plot for PC2 (Figure 5). Based on the PC2 loading values (Table 2, Figure 
5), cytoplasmic amino acid count had the highest loading value of 0.193. Similarly, some 
of the other parameters with high loadings value were number of Cytoplasmic Negative 
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Charges, number of Cytoplasmic Glutamic Acid (E), number of Cytoplasmic Leucine 
(L), number of Cytoplasmic Valine (V), number of Cytoplasmic Serine (S), Cytoplasmic 
positive Charges, Number of Phosphorylation Sites, number of Cytoplasmic Alanine(A), 
number of Cytoplasmic Aspartic Acid (D), number of Cytoplasmic Glutamate (Q), 
number of Cytoplasmic Threonine (T) and number of Cytoplasmic Arginine (R). As 
indicated in (Figure 5 and Appendix B), the variables that are related to cytoplasmic 
topological domain contribute the most to PC2.  
 
Figure 5. Loadings plot for 126 variables using PC1. 
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Statistical Difference and Kernel Density Estimation (KDE) 
Wilcoxon ranked-sum test (equivalent to the Mann-Whitney 𝑈𝑈 test) was 
performed to determine if there was a significant difference in the median of cytoplasmic 
amino acid count between enzymes and non-enzymes. The number of type I CD proteins 
that were identified as enzymes and non-enzymes were 218 and 26, respectively 
(Appendix C). The median cytoplasmic amino acid count between enzyme and non-
enzyme was 424 and 60 respectively. The 𝑝𝑝-value was found to be 2.054e-10 which is 
much smaller than the significance level of 0.05. This result indicated that there was a 
significant difference in the distribution of cytoplasmic amino acid counts between 
enzymes and non-enzymes of Type I CD proteins. 
When the probability density functions were plotted for the cytoplasmic amino 
acid count for enzymes and non-enzymes, the probability of obtaining non-enzyme was 
extremely high in the 0 to 280 range (approximate point where enzyme and non-enzyme 
kernel density estimation curve met). However, when the cytoplasmic amino acid count 
exceeded 280, the probability of obtaining non-enzymes was quite small. At a 
cytoplasmic AA count higher than 280, the probability of obtaining enzymes was 
substantially higher. When the KDE for enzyme and non-enzyme was integrated within 
the range of 0-280, the probability of obtaining enzyme and non-enzyme within that 
range was 0.18 and 0.93, respectively. However, when the KDE for enzyme and non-
enzyme were integrated in the range of 280-1089, the respective probabilities of 
obtaining enzyme and non-enzyme were 0.79 and 0.04, respectively. 
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Figure 6.  Kernel density estimation for enzymes and non-enzymes.  
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Chapter V 
DISCUSSION 
PCA was found as an effective tool for separating enzyme and non-enzyme 
clusters for type I CD proteins. Previously, Patterson and Kang (2011) successfully 
separated enzyme and non-enzyme clusters for type II CD proteins using principal 
component analysis. Thus, the results from these two experiments help to establish 
principal component analysis as an important statistical tool for the separation and 
classification of all single-pass CD proteins based on their function. Since type I and type 
II CD proteins are a subclass of single-pass transmembrane proteins, it is proposed that 
PCA can be applied to all single-pass transmembrane proteins for the separation and 
classification of enzymes and non-enzymes.  
Prediction of Type I CD Proteins Functional Class Based on Their Cytoplasmic Amino 
Acid Counts 
 Results from this experiment indicated that the probability of a randomly selected 
type I CD protein being an enzyme or non-enzyme can be predicted based on its 
cytoplasmic amino acid count. Out of 126 protein characteristics, the 30 most important 
protein characteristics were associated with cytoplasmic domain. This finding suggested 
that the cytoplasmic domain was important for determining the enzymatic activity of a 
type I CD protein. When we assessed the catalytic function of each enzyme for type I CD 
proteins, we found that the majority of the enzymes (21 out of 26) were protein 
kinases/phosphatases kinases/phosphatases, which were involved in signal transduction, 
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and their catalytic domain was present in cytoplasmic region. Moreover, those enzymes 
involved in signal transduction had their catalytic domain present in the cytoplasmic 
region and their cytoplasmic amino acid count was substantially larger than their 
extracellular amino acid count. This clearly indicates that for a type I CD enzyme that 
participate in signal transduction, cytoplasmic domain plays a key role, which was 
consistent with our observation.  Five out of 26 enzymes were involved in peptidase and 
oxidase activity and their catalytic domain were present in the extracellular region. This 
finding suggests that for type I CD enzymes, nature is more biased towards production of 
signal transduction enzymes and prefers cytoplasmic domain for their catalytic activity. 
However, this bias is not absolute because type I CD enzymes could be involved in 
oxidation or cleavage of other proteins, and in that case the catalytic domain is present in 
the extracellular region. Also, it was found found that if a type I CD protein exists that 
have enzymatic activity other than signal transduction (peptidase and oxidase activity), its 
cytoplasmic amino acid count should be subastantly smaller compared to its extracellular 
amino acid count. In addition, the catalytic domain must be present in the extracellular 
region.  Patterson and Kang (2011) found that type II CD proteins with enzymatic 
activity had diverse function such as endopeptidases, metalloproteases, ectoenzymes, 
phosphodiesterases, phosphatases and exopeptidases. All the enzymes for type II CD 
proteins had their catalytic domains in the extracellular region. They also found that the 
extracellular amino acid count was the most important protein characteristic for 
determination of enzymatic activity for a type II CD protein. Since the C-terminus is in 
the extracellular domain for type II CD proteins, the C-terminus is very important for the 
catalytic activity of the majority of single-pass CD enzymes.  
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Since the advent of genome sequencing, the number of novel protein sequences 
submitted to the UniProt database has grown in an unprecedented way (Mills, Beuning, 
& Ondrechen, 2015). This  method of predicting protein function is broadly applicable 
because it is a simple tool compared to currently available tools for function prediction. 
Most of the currently available tools for predicting function depend on the comparison of 
the uncharacterized protein with a protein having similar structure or function. They use 
complex algorithms, and many times the functions are incorrectly annotated (Mills et al., 
2015). The prediction tool that has been developed from this experiment is quite simple 
and does not require comparison of sequence or structure to proteins with experimentally 
verified function. This method employs a well-established statistical method (principal 
component analysis) to identify the most important protein characteristics responsible for 
separation of enzymes and non-enzymes.  Based on the kernel density estimation (KDE) 
of the protein characteristics (cytoplasmic amino acid count for type I CD proteins), 
anyone can predict whether a newly discovered protein or poorly characterized protein 
will be an enzyme or non-enzyme.  
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APPENDIX A: 
Mahalnobis Distance, Hotelling’s T-squared Values and F-statistics for each 
Combinations of Principle Components for PC1 to PC10.  
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Appendix A: Mahalanobis distance, Hotelling’s T-squared values and F-statistics for 
each combinations of principle components for PC1 to PC10. As highlighted in bold, 
the highest F-statistics values corresponds to the score plots having one of the 
component as PC2. 
PCs Used Dm Dm 2 Hot T2 F-stat F-critical 
PC1-PC2 5.65 31.89 740.82 368.88 3.03 
PC1-PC3 1.51 2.29 53.28 26.53 
 
PC1-PC4 1.34 1.79 41.49 20.66 
 
PC1-PC5 1.34 1.78 41.43 20.63 
 
PC1-PC6 1.35 1.81 42.03 20.93 
 
PC1-PC7 1.79 3.20 74.34 37.02 
 
PC1-PC8 1.36 1.85 43.09 21.46 
 
PC1-PC9 1.34 1.79 41.53 20.68 
 
PC1-PC10 1.36 1.86 43.12 21.47 
 
PC2-PC3 3.51 12.29 285.60 142.21 
 
PC2-PC4 3.26 10.65 247.42 123.20 
 
PC2-PC5 3.26 10.64 247.24 123.11 
 
PC2-PC6 3.27 10.72 249.13 124.05 
 
PC2-PC7 3.88 15.02 348.87 173.72 
 
PC2-PC8 3.30 10.88 252.71 125.83 
 
PC2-PC9 3.26 10.66 247.58 123.28 
 
PC2-PC10 3.30 10.88 252.78 125.87 
 
PC3-PC4 0.14 0.02 0.47 0.23 
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PC3-PC5 0.14 0.02 0.46 0.23 
 
PC3-PC6 0.15 0.02 0.51 0.26 
 
PC3-PC7 0.50 0.25 5.91 2.94 
 
PC3-PC8 0.16 0.03 0.61 0.30 
 
PC3-PC9 0.14 0.02 0.47 0.23 
 
PC3-PC10 0.16 0.03 0.62 0.31 
 
PC4-PC5 0.00 0.00 0.00 0.00 
 
PC4-PC6 0.01 0.00 0.00 0.00 
 
PC4-PC7 0.35 0.13 2.92 1.46 
 
PC4-PC8 0.02 0.00 0.01 0.01 
 
PC4-PC9 0.00 0.00 0.00 0.00 
 
PC4-PC10 0.02 0.00 0.01 0.01 
 
PC5-PC6 0.01 0.00 0.00 0.00 
 
PC5-PC7 0.35 0.13 2.91 1.45 
 
PC5-PC8 0.02 0.00 0.01 0.01 
 
PC5-PC9 0.00 0.00 0.00 0.00 
 
PC5-PC10 0.02 0.00 0.01 0.01 
 
PC6-PC7 0.36 0.13 3.04 1.52 
 
PC6-PC8 0.03 0.00 0.02 0.01 
 
PC6-PC9 0.01 0.00 0.00 0.00 
 
PC6-PC10 0.03 0.00 0.02 0.01 
 
PC7-PC8 0.38 0.14 3.29 1.64 
 
PC7-PC9 0.36 0.13 2.93 1.46 
 
 38 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PC7-PC10 0.38 0.14 3.30 1.64 
 
PC8-PC9 0.02 0.00 0.01 0.01 
 
PC8-PC10 0.04 0.00 0.04 0.02 
 
PC9-PC10 0.02 0.00 0.01 0.01 
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APPENDIX B: 
Loadings Values of PC1 to PC10 for 126 Different Physicochemical Properties.
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Appendix B: Loadings values of PC1 to PC10 for 126 different physicochemical properties. 
Variables PC1 PC2 PC3 PC4 PC5 PC6 PC7 PC8 PC9 PC10 
Extracellular Length 0.140 -0.089 0.002 0.005 -0.016 -0.019 -0.006 0.013 0.003 0.022 
Transmembrane Length 0.015 -0.044 0.076 0.052 -0.065 0.053 -0.060 -0.167 0.124 0.070 
Cytoplasmic Length 0.071 0.193 0.005 0.012 -0.020 0.006 0.010 -0.002 0.015 0.021 
Total Length 0.153 -0.015 0.004 0.009 -0.021 -0.015 -0.003 0.011 0.008 0.027 
Extracellular + Charges 0.138 -0.084 -0.020 0.006 -0.014 0.020 -0.030 -0.015 0.019 0.025 
Extracellular Negative Charges 0.139 -0.085 0.018 0.001 0.010 0.044 -0.018 -0.013 -0.019 -0.054 
Total Extracellular Charges -0.105 0.068 -0.111 0.014 -0.069 -0.095 -0.016 0.005 0.111 0.243 
Transmembrane + Charges -0.018 -0.020 0.020 -0.303 -0.250 0.259 0.028 0.087 -0.108 0.133 
Transmembrane Neg Charges -0.027 -0.010 0.015 0.331 -0.042 0.266 0.054 0.224 -0.116 0.045 
Total Transmembrane Charges 0.008 -0.006 0.002 -0.438 -0.136 -0.020 -0.020 -0.103 0.012 0.056 
Cytoplasmic + Charges 0.069 0.183 -0.036 0.032 -0.001 0.022 -0.080 0.025 0.042 0.060 
Cytoplasmic Neg Charges 0.070 0.189 0.027 0.004 0.013 0.032 0.030 -0.023 -0.020 0.023 
Total Cytoplasmic Charges -0.039 -0.114 -0.143 0.056 -0.036 -0.036 -0.239 0.110 0.136 0.062 
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Total + Charges 0.149 -0.007 -0.031 0.016 -0.014 0.027 -0.056 -0.004 0.032 0.045 
Total  Neg Charges 0.151 -0.007 0.026 0.003 0.014 0.053 -0.005 -0.020 -0.025 -0.040 
Total Charges -0.109 0.007 -0.162 0.030 -0.079 -0.099 -0.124 0.053 0.159 0.240 
Extracellular Absolute Charges 0.111 -0.069 0.104 -0.019 0.048 0.068 -0.001 0.000 -0.077 -0.222 
Transmembrane Absolute 
Charges 
-0.033 -0.022 0.025 0.039 -0.206 0.380 0.060 0.229 -0.162 0.126 
Cytoplasmic Absolute Charges 0.024 0.112 0.103 0.001 0.033 0.060 0.233 -0.106 -0.077 -0.052 
Total Absolute Charges 0.111 -0.011 0.138 -0.029 0.059 0.078 0.122 -0.055 -0.123 -0.223 
Number of Extracellular A 0.117 -0.085 0.062 0.006 -0.058 -0.121 0.034 0.096 -0.036 0.057 
Number of Extracellular R 0.132 -0.084 0.036 0.015 -0.063 -0.043 0.019 0.051 0.006 0.002 
Number of Extracellular N 0.131 -0.079 -0.058 -0.006 0.028 0.069 -0.055 -0.067 0.011 -0.025 
Number of Extracellular D 0.133 -0.087 0.041 0.003 0.001 0.057 -0.027 -0.009 -0.009 -0.088 
Number of Extracellular C 0.113 -0.073 0.090 0.036 -0.059 0.067 -0.087 -0.053 0.075 -0.138 
Number of Extracellular Q 0.125 -0.095 -0.008 -0.008 -0.001 -0.057 0.068 0.042 -0.003 0.027 
Number of Extracellular E 0.137 -0.077 -0.012 -0.001 0.023 0.024 -0.006 -0.018 -0.028 -0.009 
Number of Extracellular G 0.130 -0.093 0.056 0.017 -0.039 -0.035 -0.016 0.042 0.013 0.023 
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Number of Extracellular H 0.130 -0.073 0.017 0.001 -0.055 -0.055 -0.001 0.063 0.028 0.016 
Number of Extracellular I 0.130 -0.072 -0.073 -0.017 0.056 0.084 -0.022 -0.074 -0.009 0.021 
Number of Extracellular L 0.123 -0.075 -0.118 -0.004 -0.032 -0.093 0.073 0.090 -0.017 0.004 
Number of Extracellular K 0.124 -0.071 -0.083 -0.005 0.046 0.091 -0.083 -0.090 0.032 0.048 
Number of Extracellular M 0.128 -0.076 -0.038 -0.004 0.007 0.042 0.018 0.006 -0.003 -0.013 
Number of Extracellular F 0.127 -0.085 -0.094 -0.012 0.000 0.004 0.021 0.002 0.019 0.034 
Number of Extracellular P 0.112 -0.075 0.105 0.023 -0.064 -0.127 -0.030 0.076 0.028 0.100 
Number of Extracellular S 0.132 -0.085 0.000 0.007 -0.028 -0.059 -0.017 0.020 0.013 0.094 
Number of Extracellular T 0.125 -0.075 0.052 -0.003 0.014 -0.045 -0.054 0.009 -0.031 0.078 
Number of Extracellular W 0.108 -0.077 0.019 0.034 -0.021 -0.005 0.037 -0.036 0.030 -0.036 
Number of Extracellular Y 0.130 -0.081 -0.032 0.007 0.025 0.057 0.003 -0.050 0.024 0.040 
Number of Extracellular V 0.131 -0.074 -0.021 -0.005 0.013 -0.028 0.049 0.005 -0.045 0.099 
Number of Transmembrane A -0.003 -0.022 0.024 0.029 -0.038 -0.137 -0.135 -0.058 -0.216 0.047 
Number of Transmembrane R -0.016 -0.006 0.006 -0.150 -0.169 0.100 0.013 0.013 -0.027 0.037 
Number of Transmembrane N -0.012 0.001 -0.028 0.028 -0.043 -0.010 0.067 -0.125 0.114 -0.097 
Number of Transmembrane D -0.022 -0.007 0.010 0.262 -0.025 0.218 0.023 0.191 -0.057 0.025 
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Number of Transmembrane C -0.007 0.046 -0.038 0.047 0.006 0.009 -0.089 -0.078 0.146 -0.102 
Number of Transmembrane Q -0.012 -0.017 -0.027 0.029 -0.039 -0.057 -0.022 0.099 0.092 -0.061 
Number of Transmembrane E -0.019 -0.009 0.013 0.239 -0.041 0.184 0.063 0.144 -0.124 0.045 
Number of Transmembrane G -0.013 -0.054 -0.005 0.083 -0.072 -0.160 0.054 -0.140 -0.125 0.120 
Number of Transmembrane H 0.015 -0.015 -0.007 0.012 -0.105 -0.002 0.082 0.021 0.106 -0.218 
Number of Transmembrane I 0.016 0.018 0.017 -0.103 0.230 0.098 -0.070 -0.160 -0.055 0.034 
Number of Transmembrane L 0.027 -0.022 0.091 -0.032 -0.026 -0.066 0.198 0.303 0.203 0.005 
Number of Transmembrane K -0.011 -0.019 0.019 -0.259 -0.188 0.238 0.025 0.092 -0.108 0.131 
Number of Transmembrane M -0.001 0.000 -0.128 0.037 -0.009 0.079 -0.093 0.041 0.136 0.000 
Number of Transmembrane F -0.014 -0.001 -0.031 -0.019 -0.045 0.081 0.043 -0.059 0.221 -0.020 
Number of Transmembrane P -0.001 -0.012 0.045 0.055 -0.086 0.099 0.050 -0.075 0.160 -0.094 
Number of Transmembrane S -0.007 0.006 0.009 -0.016 -0.167 0.101 0.032 -0.095 0.036 -0.076 
Number of Transmembrane T -0.002 0.010 -0.130 0.068 -0.163 -0.039 -0.062 -0.180 -0.057 -0.006 
Number of Transmembrane W 0.019 -0.017 0.004 0.073 0.014 0.123 0.067 0.033 0.246 -0.063 
Number of Transmembrane Y 0.009 0.000 -0.046 0.067 -0.039 0.042 -0.053 -0.115 0.008 0.068 
Number of Transmembrane V -0.011 0.007 0.059 -0.001 0.086 -0.007 -0.157 -0.045 -0.219 0.066 
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Number of Cytoplasmic A 0.062 0.182 0.058 0.019 -0.026 -0.043 0.014 0.047 0.006 0.015 
Number of Cytoplasmic R 0.062 0.175 0.002 0.048 -0.037 -0.019 -0.016 0.085 0.068 0.032 
Number of Cytoplasmic N 0.072 0.160 -0.044 0.010 0.010 0.059 -0.087 -0.032 -0.010 0.072 
Number of Cytoplasmic D 0.069 0.182 0.029 -0.002 0.014 0.046 0.028 -0.015 -0.017 0.017 
Number of Cytoplasmic C 0.051 0.170 -0.016 -0.006 -0.081 -0.016 0.042 -0.034 0.042 -0.049 
Number of Cytoplasmic Q 0.060 0.178 0.044 0.022 -0.037 -0.011 0.047 0.009 0.051 0.045 
Number of Cytoplasmic E 0.068 0.186 0.024 0.008 0.012 0.019 0.030 -0.029 -0.021 0.027 
Number of Cytoplasmic G 0.064 0.174 0.067 0.024 -0.034 -0.010 0.090 -0.014 0.003 -0.014 
Number of Cytoplasmic H 0.069 0.166 -0.022 0.019 -0.024 -0.021 -0.024 -0.001 0.041 0.061 
Number of Cytoplasmic I 0.068 0.170 -0.085 -0.008 0.011 0.045 -0.113 0.001 -0.003 0.036 
Number of Cytoplasmic L 0.067 0.186 -0.021 0.006 -0.046 -0.002 -0.008 0.045 0.003 -0.037 
Number of Cytoplasmic K 0.067 0.165 -0.068 0.012 0.034 0.059 -0.132 -0.038 0.011 0.079 
Number of Cytoplasmic M 0.070 0.165 -0.021 0.010 0.005 0.024 -0.062 0.004 -0.032 0.038 
Number of Cytoplasmic F 0.074 0.171 -0.083 -0.013 -0.015 0.016 -0.021 -0.005 0.017 0.019 
Number of Cytoplasmic P 0.053 0.168 0.090 0.010 -0.044 -0.033 0.146 -0.034 0.028 0.023 
Number of Cytoplasmic S 0.061 0.185 0.024 0.006 -0.022 0.004 0.067 -0.049 0.025 0.023 
          
45 
  
Number of Cytoplasmic T 0.063 0.177 0.029 0.014 -0.022 0.008 -0.010 0.002 0.082 0.037 
Number of Cytoplasmic W 0.052 0.164 -0.090 -0.015 -0.079 -0.014 0.002 0.054 0.000 -0.088 
Number of Cytoplasmic Y 0.069 0.169 -0.063 0.016 0.026 0.018 -0.052 0.004 -0.042 0.033 
Number of Cytoplasmic V 0.068 0.186 -0.010 0.009 -0.026 0.002 -0.017 0.015 0.024 0.013 
Total number of A 0.130 -0.020 0.078 0.014 -0.065 -0.134 0.029 0.102 -0.043 0.061 
Total number of R 0.142 -0.015 0.034 0.030 -0.071 -0.046 0.012 0.077 0.029 0.013 
Total number of N 0.139 -0.033 -0.064 -0.003 0.028 0.079 -0.072 -0.071 0.008 -0.006 
Total Number of D 0.145 -0.026 0.047 0.004 0.005 0.068 -0.017 -0.012 -0.014 -0.077 
Total number of C 0.119 -0.049 0.086 0.036 -0.069 0.065 -0.083 -0.060 0.085 -0.147 
Total number of Q 0.140 -0.022 0.009 0.001 -0.016 -0.058 0.081 0.044 0.018 0.041 
Total number of E 0.147 0.015 0.000 0.004 0.025 0.030 0.009 -0.027 -0.034 0.005 
Total number of G 0.142 -0.035 0.073 0.026 -0.050 -0.042 0.015 0.030 0.008 0.022 
Total number of H 0.139 -0.018 0.009 0.006 -0.059 -0.056 -0.007 0.058 0.039 0.028 
Total number of I 0.137 -0.010 -0.089 -0.026 0.072 0.096 -0.060 -0.079 -0.014 0.032 
Total number of L 0.135 0.005 -0.106 -0.003 -0.048 -0.087 0.073 0.114 -0.002 -0.011 
Total number of K 0.131 0.004 -0.097 -0.001 0.051 0.102 -0.122 -0.091 0.031 0.073 
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Total number of M 0.138 0.021 -0.050 0.005 0.008 0.052 -0.024 0.010 -0.008 0.009 
Total number of F 0.138 -0.019 -0.115 -0.016 -0.008 0.015 0.015 -0.004 0.039 0.035 
Total number of P 0.123 0.006 0.134 0.026 -0.077 -0.125 0.038 0.052 0.040 0.097 
Total number of S 0.144 -0.008 0.010 0.009 -0.038 -0.050 0.011 -0.003 0.023 0.093 
Total number of T 0.136 -0.019 0.053 0.004 0.002 -0.042 -0.056 0.003 -0.007 0.084 
Total number of W 0.119 -0.038 -0.002 0.035 -0.038 0.000 0.041 -0.021 0.045 -0.059 
Total number of Y 0.142 -0.007 -0.055 0.015 0.031 0.059 -0.020 -0.048 0.006 0.051 
Total number of V 0.142 -0.002 -0.019 -0.002 0.009 -0.025 0.028 0.007 -0.047 0.099 
pI Extracellular -0.027 0.005 -0.059 -0.024 -0.139 -0.104 -0.024 0.049 0.151 0.210 
Instability Index Extra -0.015 0.036 0.155 0.088 -0.151 -0.106 -0.070 0.084 0.072 -0.134 
Aliphatic Index Extra 0.024 0.000 -0.328 -0.018 0.080 -0.052 0.234 0.052 -0.103 0.025 
Hydropathicity Extra 0.021 -0.012 -0.241 0.007 0.003 -0.122 0.232 0.074 -0.043 -0.006 
pI Transmembrane 0.002 -0.020 0.015 -0.384 -0.225 0.121 0.030 -0.015 -0.002 0.021 
Instability Index Trans 0.011 0.004 0.005 -0.007 0.054 0.139 0.098 0.078 0.246 -0.145 
Aliphatic Index Trans 0.030 0.016 0.142 -0.157 0.278 -0.042 0.063 0.245 -0.065 0.060 
Hydropathicity Trans 0.020 0.038 0.108 -0.169 0.357 -0.064 -0.054 0.153 -0.055 0.065 
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pI Cytoplasmic -0.037 -0.073 -0.125 0.050 -0.032 0.023 -0.149 0.113 0.151 0.063 
Instability Index Cyto -0.027 -0.013 0.043 -0.024 -0.037 -0.020 0.205 0.073 0.096 0.081 
Aliphatic Index Cyto 0.021 0.085 -0.103 -0.071 -0.065 -0.045 -0.168 0.135 -0.096 -0.277 
Hydropathicity Cyto 0.024 0.090 -0.082 -0.117 -0.112 -0.110 -0.065 0.089 -0.106 -0.268 
Number of Glycosolation Sites 
E 
0.099 -0.046 -0.025 -0.013 0.050 0.015 -0.053 -0.120 0.013 0.054 
Number of Phosphorylation 
Sites 
0.062 0.183 0.033 0.013 0.006 -0.001 0.033 -0.042 0.015 0.057 
Helix Content of Extracellular 0.031 -0.018 -0.259 -0.072 0.038 -0.119 0.202 0.076 -0.073 -0.058 
Beta Sheet Contect Extra (%) -0.018 0.011 -0.012 0.085 0.129 0.215 0.050 -0.110 0.007 0.126 
Random Coil Content of Extra 
(%) 
-0.019 0.010 0.290 0.010 -0.145 -0.044 -0.259 0.006 0.074 -0.038 
Helix Content of Cytoplasmic 
(%) 
0.031 0.045 -0.034 0.035 0.066 0.001 -0.202 0.193 -0.157 -0.050 
Beta Sheet Content of Cyto 
(%) 
-0.008 -0.033 -0.142 -0.088 0.006 0.062 -0.011 0.077 0.159 -0.068 
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Random Coil Content of Cyto 
(%) 
-0.029 -0.027 0.145 0.025 -0.080 -0.047 0.238 -0.277 0.059 0.109 
Extracellular Disorder Average -0.033 -0.001 0.218 -0.013 0.001 -0.056 -0.118 0.059 -0.153 0.152 
Extracellular Disorder St Dev -0.006 0.018 0.186 -0.029 -0.082 -0.098 -0.169 0.142 0.106 -0.021 
Transmembrane Disorder Avg -0.015 -0.020 -0.067 0.166 -0.282 -0.105 -0.003 -0.119 -0.245 -0.052 
Transmembrane Disorder St 
Dev 
-0.011 -0.019 -0.080 0.166 -0.265 -0.105 0.024 -0.108 -0.233 -0.020 
Cytoplasmic Disorder Avg -0.016 -0.052 0.226 0.104 0.056 0.017 0.162 -0.103 0.078 0.241 
Cytoplasmic Disorder St Dev 0.044 0.112 0.103 -0.021 -0.012 -0.094 0.089 -0.020 -0.064 -0.081 
 
 
 
  
        
  
49 
  
 
 
 
 
 
 
 
 
 
 
 
Appendix C: 
Wilcoxon Ranked-Sum Test for Cytoplasmic Amino Acid Count for Enzymes and Non-enzymes 
for Type I CD Proteins   
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Appendix C: Wilcoxon Ranked-Sum Test for Cytoplasmic Amino Acid Count for 
enzymes and non-enzymes for Type I CD proteins. The two populations are 
significantly different as the p-value is less than critical value of 0.05. 
 Enzyme  Non-enzymes 
Number (n) 26 218 
Median Cytoplasmic Count 424 60 
W-value 671 
p-value 2.054e-10 
  
 
